Editorial content

Watch now: Next-Generation Antibody Technologies

The webcast features two experts from the field: Dr. Floris van Delft of Synaffix BV, and Dr. Phil Barish ofAbSci.

Go to the profile of Samia Burridge
Dec 01, 2015
0
1
Upvote 0 Comment

The webcast features two experts from the field: Dr. Floris van Delft of Synaffix BV, and Dr. Phil Barish ofAbSci. We will look at the potential of next-generation antibody technologies including ADCs. The webcast will also include a roundtable discussion and a Q&A section to allow you to participate and contribute your own thoughts on these and other aspects of the next-generation antibody technologies.

Click here for more information and to register to watch

If you’d like to be kept informed of upcoming webcast topics, and you are a member of this site, simply follow me for updates. If you’re not yet a member, you can register for the BioPharma Dealmakers e-alert here

Find out more about how your company can take part in a Nature.com Webcast.

Go to the profile of Samia Burridge

Samia Burridge

Business Development Manager, Nature Research Group

See my linkedIn profile for Bio/Expertise

1 Comments

Go to the profile of Candy Swift
Candy Swift about 2 years ago

Creative Biolabs is the industry leading expert in antibody engineering and can utilise our experience to provide comprehensive services for the conjugation and characterisation of antibody-drug conjugates. With years of experience in a variety of cell based bioassays and binding assays, we provide comprehensive expertise to support the development of antibody-drug conjugate products for all phases of drug development from discovery to GMP manufacturing.

http://www.creative-biolabs.com/Antibody-Drug-Conjugation-Service.html